Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- CheckyesterdayChange DetectedRemoved a MedlinePlus Genetics topic on Schizophrenia; overall page content in the genetics/health topic area is reduced.SummaryDifference0.2%
- Check8 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%
- Check15 days agoChange DetectedPage version updated to v3.1.0 with a new MedlinePlus Genetics topic on Schizophrenia; previous version v3.0.2 removed.SummaryDifference0.3%
- Check22 days agoChange Detected- Removed a MedlinePlus Genetics topic on schizophrenia, narrowing the page's coverage of that condition.SummaryDifference0.2%
- Check29 days agoChange DetectedUpdated the page to revision v3.0.2 and removed the 'Back to Top' link; no substantive content changes were detected.SummaryDifference0.2%
- Check36 days agoChange DetectedThe web page has been updated to include information on Schizophrenia under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.4%
Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.